An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs
Early Phase 1
Terminated
- Conditions
- Pancreatic Cancer
- Interventions
- Drug: [18]F-FLT PET scan
- First Posted Date
- 2006-12-21
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 11
- Registration Number
- NCT00414570
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL
Phase 2
Withdrawn
- Conditions
- Lymphoma
- First Posted Date
- 2006-12-21
- Last Posted Date
- 2016-02-15
- Lead Sponsor
- AHS Cancer Control Alberta
- Registration Number
- NCT00414089
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
The Utility of FDG-PET for Radiation Treatment in NSCLC
- Conditions
- Positron Emission TomographyLung Neoplasms
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2017-07-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 50
- Registration Number
- NCT00385164
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Evaluating Taste and Smell Function and Food and Taste Preferences of Head and Neck Cancer Patients During Radiation Therapy/Chemotherapy
Completed
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 100
- Registration Number
- NCT00375921
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy
Not Applicable
Withdrawn
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Registration Number
- NCT00375700
Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients
Completed
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2006-09-12
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 100
- Registration Number
- NCT00375180
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Study to Determine the Utility of FES-PET and FDG-PET in the Prediction of Response to Hormone Therapy in Women With Estrogen Positive Metastatic Breast Cancer
Terminated
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2006-07-28
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 51
- Registration Number
- NCT00358098
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours
Not Applicable
Completed
- Conditions
- Lung NeoplasmsLung Cancer
- Interventions
- Procedure: Fractionated Stereotactic Radiotherapy
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2017-09-21
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 58
- Registration Number
- NCT00351962
- Locations
- π¨π¦
Tom Baker Cancer Center, Calgary, Alberta, Canada
Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients
- First Posted Date
- 2006-07-13
- Last Posted Date
- 2019-10-21
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 5
- Registration Number
- NCT00351715
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
π¨π¦Tom Baker Cancer Center, Calgary, Alberta, Canada
Identification of Clinically Occult Glioma Cells and Characterization of Glioma Behavior Through Machine Learning Analysis of Advanced Imaging Technology
Not Applicable
- Conditions
- Glioma
- First Posted Date
- 2006-05-25
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 113
- Registration Number
- NCT00330109
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Β© Copyright 2025. All Rights Reserved by MedPath